Glutamate and NMDA receptors activation leads to cerebellar dysfunction and impaired motor coordination in unilateral 6-hydroxydopamine lesioned Parkinson's rat: Functional recovery with bone marrow cells, serotonin and GABA

Molecular and Cellular Biochemistry

Volumn 353, Issue 1-2, 2011, Pages 47-57

  Nandhu, M S ^a   Paul, Jes ^a   Kuruvila, Korah P ^a   Abraham, Pretty M ^a   Antony, Sherin ^a   Paulose, C S ^a  

^a Department of Physics   (India)

Author keywords

Bone marrow cells; Cerebellum; Gamma aminobutyric acid; Glutamate receptor; Parkinson's disease; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; ACTIVATING TRANSCRIPTION FACTOR 4; CYCLIC AMP; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; OXIDOPAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CEREBELLUM; CEREBELLUM DISEASE; CONTROLLED STUDY; DOWN REGULATION; EXCITOTOXICITY; GENE AMPLIFICATION; GENE EXPRESSION; HIPPOCAMPUS; MALE; MOLECULAR GENETICS; MOTOR DYSFUNCTION; NONHUMAN; PARKINSON DISEASE; RAT; REAL TIME POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BINDING, COMPETITIVE; CEREBELLAR DISEASES; CEREBELLUM; CYCLIC AMP; DIZOCILPINE MALEATE; INOSITOL PHOSPHATES; MALE; MICROSCOPY, CONFOCAL; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 79959283837     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0773-x     Document Type: Article

References (50)

1. Thomas B, Beal MF (2007) Parkinson's disease. Human Mol Genet 16(2):183-194
2. Gerlach M, Gsell W, Kornhuber J et al (1996) A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome. Brain Res 741:142-152
3. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23:1261-1276
4. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695 (Pubitemid 23350687)
5. Greene JG, Greenamyre JT (1996) Bioenergetics and glutamate excitotoxicity. Prog Neurobiol 48:613-634 (Pubitemid 26194341)
6. Doble A (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81:163-221
7. Jiao J, Nakajima A, Janssen WGM et al (2008) Expression of NR2B in cerebellar granule cells specifically facilitates effect of motor training on motor learning. PLoS ONE 3:1684
8. Fiez JA, Raife EA, Balota DA et al (1996) Positron emission tomography study of the short-term maintenance of verbal information. J Neurosci 16:808-822 (Pubitemid 26028837)
9. Allen G, Buxton RB, Wong EC et al (1997) Attentional activation of the cerebellum independent of motor involvement. Science 275:1940-1943 (Pubitemid 27148817)
10. Schmahmann JD, Sherman JC (1998) The cerebellar cognitive affective syndrome. Brain 121:561-579 (Pubitemid 28162120)
11. Ploghause A, Tracey I, Gati JS et al (1999) Dissociating pain from its anticipation in the human brain. Science 284:1979-1981 (Pubitemid 29309443)
12. Parsons LM, Egan G, Liotti M et al (2001) Neuroimaging evidence implicating cerebellum in the experience of hypercapnea and hunger for air. Proc Natl Acad Sci USA 98:2041-2046 (Pubitemid 32165619)
13. Imazumi H, Miyauchi S, Tamada T et al (2004) Human cerebellar activity reflecting an acquired internal model of a new tool. Nature 3:192-195 (Pubitemid 30050961)
14. Hermann B, Seidenberg M, Sears L et al (2004) Cerebellar atrophy in temporal lobe epilepsy affects procedural memory. Neurology 63:2129-2131 (Pubitemid 39636263)
15. Baloh RW, Jacobson KM, Beykirch K, Honrubia V (1998) Static and dynamic posturography in patients with vestibular and cerebellar lesions. Arch Neurol 55(5):649-654 (Pubitemid 28224295)
16. Ho BC, Mola C, Andreasen NC (2004) Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biol Psychiatry 55(12):1146-1153 (Pubitemid 38739448)
17. Marvel CL, Schwartz BL, Rosse RB (2004) A quantitative measure of postural sway deficits in schizophrenia. Schizophr Res 68(2-3):363-372 (Pubitemid 38526157)
18. Poewe W (2009) Treatments for Parkinson disease - past achievements and current clinical needs. Neurology 72(7):65-73
19. Olanow CW (2009) Can we achieve neuroprotection with currently available anti-parkinsonian interventions? Neurology 72(7):59-64
20. Esposito E, Giovanni GD, Matteo VD (2008) Serotonin-dopamine interaction: an overview. In: Esposito E, Giovanni GD, Matteo VD (eds), Progress in Brain Res 172. doi:10.1016/S0079-6123(08)00901-1
21. Caterson EJ, Nesti LJ, Danielson K, Tuan RS (2002) Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol 20(3):245-256 (Pubitemid 34252636)
22. Park KW, Eglitis MA, Mouradian MM (2001) Protection of nigral neurons by GDNF-engineered marrow cell transplantation. Neurosci Res 40:315-323 (Pubitemid 32703878)
23. Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:95-122
24. 3H] dopa in various regions of the brain. J Neurochem 13:655-669
25. Dunham NW, Miya TS (1957) A Note on a simple apparatus for detecting neurological deficit in rats & mice. J Am Pharmaceut Assoc Sci Edit XLVI:208-209
26. 3H] glutamate binding sites in the rat central nervous system. J Neurosci 4:2133-2144
27. Hoffman DJ, Zanelli SA, Kubin JM, Om P, Delivoria PM (1996) The in vivo effect of bilirubin on the N-methyl-D-aspartate receptor/ion channel complex in the brains of newborn piglets. Pediatr Res 40:804-808
28. Lowry OH, Rosenbrough NH, Farr AL, Randall RJ (1951) Protein measurement with folin Phenol reagent. J Biol Chem 193:265-275
29. Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51(4):660-672
30. Chen S, Kobayashi M, Honda Y, Kakuta S, Sato F, Kishi K (2007) Preferential neuron loss in rat piriform cortex following pilocarpine induced status epilepticus. Epilepsy Res 74:1-18 (Pubitemid 46413702)
31. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415-455
32. Giovanni GD, Di Matteo V, Pierucci M, Benigno A, Esposito E (2006) Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies? Curr Med Chem 13(25):3069-3081
33. 2C receptors in the control of central dopamine function. Trends Pharmacol Sci 22:229-232
34. Katagiri H, Tanaka K, Manabe T (2001) Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction. Eur J Neurosci 14:547-553 (Pubitemid 34203462)
35. Bleakman D, Rusin KI, Chard PS, Glaum SR, Miller RJ (1992) Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn. Mol Pharmacol 42:192-196
36. Cerne R, Randic M (1992) Modulation of AMPA and NMDA responses in rat spinal dorsal horn neurons by trans-1-aminocyclopentane-1,3-dicarboxylic acid. Neurosci Lett 144:180-184
37. Benquet P, Gee CE, Gerber U (2002) Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes. J Neurosci 22:9679-9686 (Pubitemid 35332851)
38. Fujii S, Sasaki H, Mikoshiba K et al (2004) A chemical LTP induced by co-activation of metabotropic and N-methyl-D-aspartate glutamate receptors in hippocampal CA1 neurons. Brain Res 999:20-28 (Pubitemid 38121448)
39. Conn PJ, Pin JP (1997) Pharmacology and function of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237 (Pubitemid 27238875)
40. Aramori I, Nakanishi S (1992) Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells. Neuron 8:757-765
41. Joly C, Gomeza J, Brabet I, Curry K, Bockaert J, Pin JP (1995) Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1. J Neurosci 15:3970-3981
42. Shacka JJ, Roth KA (2005) Regulation of neuronal cell death and neurodegeneration by members of the bcl-2 family: therapeutic implications. Curr Drug Targets CNS Neurol Disord 4:25-39 (Pubitemid 41408406)
43. Walton MR, Dragunow I (2000) Is CREB a key to neuronal survival? Trends Neurosci 23(2):48-53
44. Finkbeiner S (2000) CREB couples neurotrophin signals to survival messages. Neuron 25(1):11-14
45. Shimamura A, Ballif BA, Richards SA, Blenis J (2000) Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr Biol 10(3):127-135 (Pubitemid 30115743)
46. Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2(8):599-609 (Pubitemid 33674011)
47. Cendelín J, Korelusová I, Vozeh F (2008) The effect of repeated rotarod training on motor skills and spatial learning ability in Lurcher mutant mice. Behav Brain Res 189:65-74
48. Mussa-Ivaldi FA, Bizzi E (2000) Motor learning through the combination of primitives. Philos Trans R Soc Lond B Biol Sci 355:1755-1769 (Pubitemid 32116940)
49. Krakauer JW, Shadmehr R (2006) Consolidation of motor memory. PLoS Biol 4:e316
50. Hellmann MA, Panet H, Barhum Y, Melamed E, Offen D (2005) Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett 395(2):124-128